← Eichor
Study identifier: NCT05832307 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

Condition: Influenza  ·  Sponsor: University of Colorado, Denver

PhaseNA
Planned participants22000
Who can joinAll sexes, 6 Months to 99 Years
Healthy volunteersYes

About this study

This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.

This description comes directly from the study's public registry record.

Talk to the study team

Suchitra Rao  ·  7207772823  ·  suchitra.rao@childrenscolorado.org

Always discuss trial participation with your own doctor first.

Locations (2)

Ann and Robert Lurie's Children Hospital of ChicagoChicago, Illinois, United StatesRecruiting
Seattle Children's HospitalSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05832307